p = 0.034) and total daily insulin dose (-0.29
Associate Professor, Department of Pediatrics and Medicine, Geisel School of Medicine at Dartmouth
Some insurers cover Wegovy specifically for weight loss, while others may cover Ozempic only for diabetes but allow off-label use for weight reduction when clinically appropriate
Our providers evaluate patients with conditions such as diabetes, insulin resistance, and PCOS to develop personalized weight loss plans
Patients may also receive digital health coaching for ongoing support and to track their progress
From their beginnings as a treatment for type 2 diabetes, GLP-1 receptor agonists such as semaglutide and tirzepatide have seen an explosion in use, most popularly for weight loss